Lack of sensitivity to the TRAIL apoptotic pathway can be explained by different mechanisms involving reduced expression of the death receptors (only a minority of the AML cells express TRAIL-R1 and TRAIL-R2) [33]. The gene discussed is TNFSF10; the disease is acute myeloid leukemia.